Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells

Retrovirology

Volumn 1, Issue , 2004, Pages

  Chen, Xiaochuan ^a   He, Jin ^a   Chang, Lung Ji ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD209 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; T6 ANTIGEN; PRIMER DNA;

ARTICLE; BLOOD DONOR; CELL FUNCTION; CELL POLARITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; GENETIC CODE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; NONHUMAN; NORMAL HUMAN; PHENOTYPE; RECEPTOR DOWN REGULATION; T LYMPHOCYTE; TH1 CELL; CD4+ T LYMPHOCYTE; CYTOLOGY; FLOW CYTOMETRY; GENE VECTOR; GENETICS; IMMUNOLOGY; LENTIVIRINAE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; VIROLOGY;

BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DNA PRIMERS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; IMMUNITY, CELLULAR; LENTIVIRUS; MOLECULAR SEQUENCE DATA; MONOCYTES; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 18144413140     PISSN: 17424690     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4690-1-37     Document Type: Article

References (43)

1. Lore K, Sonnerborg A, Brostrom C, Goh LE, Perrin L, McDade H, Stellbrink HJ, Gazzard B, Weber R, Napolitano LA, van Kooyk Y, Andersson J: Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. Aids 2002, 16:683-692.
2. Servet C, Zitvogel L, Hosmalin A: Dendritic cells in innate immune responses against HIV. Curr Mol Med 2002, 2: 739-756.
3. Chougnet C, Cohen SS, Kawamura T, Landay AL, Kessler HA, Thomas E, Blauvelt A, Shearer GM: Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J Immunol 1999, 163: 1666-1673.
4. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S: Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002, 20:621-667.
5. Lipscomb MF, Masten BJ: Dendritic cells: immune regulators in health and disease. Physiol Rev 2002, 82:97-130.
6. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. [Review]. Annual Review of Immunology 1989, 7:145-173.
7. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML: T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999, 20:561-567.
8. Chambers CA: The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol 2001, 22: 217-223.
9. Chirathaworn C, Kohlmeier JE, Tibbetts SA, Rumsey LM, Chan MA, Benedict SH: Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation. J Immunol 2002, 168:5530-5537.
10. Salomon B, Bluestone JA: LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J Immunol 1998, 161:5138-5142.
11. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LDJ: DNA-based immunization by in vivo transfection of dendritic cells. Nature Medicine 1996, 2:1122-1128.
12. Liu M: Transfected human dendritic cells as cancer vaccines. Nature Biotechnology 1998, 16:335-336.
13. Schroers R, Sinha I, Segall H, Schmidt-Wolf IG, Rooney CM, Brenner MK, Sutton RE, Chen SY: Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther 2000, 1:171-179.
14. Gruber A, Kan-Mitchell J, Kuhen KL, Mukai T, Wong-Staal F: Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 2000, 96: 1327-1333.
15. Chang LJ, Gay EE: The molecular genetics of lentiviral vectors - current and future perspectives. Current Gene Therapy 2001, 1:237-251.
16. Dyall J, Latouche JB, Schnell S, Sadelain M: Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 2001, 97:114-121.
17. Chang LJ, Zhang C: Infection and replication of Tat-minus human immunodeficiency viruses: genetic analyses of LTR and tat mutants in primary and long-term human lymphoid cells. Virology 1995, 211:157-169.
18. Thurner B, Roder C, Dieckmann D, Heuer M, Kruse M, Glaser A, Keikavoussi P, Kampgen E, Bender A, Schuler G: Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999, 223:1-15.
19. Zaiss AK, Son S, Chang LJ: RNA 3′-readthrough of oncoretrovirus and lentivirus: implications in vector safety and efficacy. Journal of Virology 2002, 76:7209-7219.
20. Chang LJ, Zaiss AK: Methods for the preparation and use of lentivirus vectors. In Gene Therapy Protocols Volume 2. 2nd edition. Edited by: Morgan J., Humana Press, Inc.; 2001:303-318.
21. Parney IF, Petruk KC, Zhang C, Farr-Jones M, Sykes DB, Chang LJ: Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model. Human Gene Therapy 1997, 8:1073-1085.
22. Chang LJ, Chen CH, Urlacher V, Lee TF: Differential apoptotic effects of primate lentivial Vpr and Vpx in mammalian cells. J Biomed Sci 2000, 7:322-333.
23. Cui Y, Chang LJ: A rapid and reliable bioassay for functional human interleukin-12 by interferon-g ELISPOT. Prep Biochem and Biotechnol 1997, 28:23-36.
24. He J, Chang LJ: Functional characterization of hepatoma-specific stem cell antigen-2. Molecular Carcinogenesis 2004, 40:90-103.
25. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J: Efficacy and safety analyses of a recombinant human immunodeficiency virus type I derived vector system. Gene Therapy 1999, 6:715-728.
26. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J, Jeannin P: Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001, 167: 3682-3686.
27. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC: Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992, 127: 183-204.
28. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM: HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci U S A 2004, 101:7669-7674.
29. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-6691.
30. Wesa AK, Galy A: Regulation of T cell cytokine production by dendritic cells generated in vitro from hematopoietic progenitor cells. Cell Immunol 2001, 208:115-124.
31. Demangel C, Bertolino P, Britton WJ: Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol 2002, 32:994-1002.
32. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G: Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001, 166:4312-4318.
33. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
34. Yue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, Manolio S, Burg G: Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 1997, 71:630-637.
35. Badou A, Bennasser Y, Moreau M, Leclerc C, Benkirane M, Bahraoui E: Tat protein of human immunodeficiency virus type 1 induces interleukin- 10 in human peripheral blood monocytes: implication of protein kinase C- dependent pathway. J Virol 2000, 74: 10551-10562.
36. Smits HH, de Jong EC, Schuitemaker JH, Geijtenbeek TB, van Kooyk Y, Kapsenberg ML, Wierenga EA: Intercellular adhesion molecule-1/LFA-1 ligation favors human Th1 development. J Immunol 2002, 168:1710-1716.
37. King CL, Xianli J, June CH, Abe R, Lee KP: CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur J Immunol 1996, 26:2448-2455.
38. Webb LM, Feldmann M: Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells. Blood 1995, 86:3479-3486.
39. Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA: CD28 costimulation promotes the production of Th2 cytokines. J Immunol 1997, 158:658-665.
40. Kato T, Nariuchi H: Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation. J Immunol 2000, 164:3554-3562.
41. Tikkanen JM, Lemstrom KB, Koskinen PK: Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response. Am J Respir Crit Care Med 2002, 165: 724-729.
42. Steinman RM: DC-SIGN: a guide to some mysteries of dendritic cells. Cell 2000, 100:491-494.
43. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.